DiaSys Diagnostic Systems

DiaSys Diagnostic Systems is an established, privately-held German in vitro diagnostics (IVD) company with a 30+ year history. It operates a classic diagnostics business model, generating revenue from the sale of reagents, calibrators, controls, and instrumentation for clinical laboratories globally. The company maintains a broad portfolio focused on routine and special chemistry, immunoturbidimetry, and urinalysis, supported by a certified quality management system. Its strategy is heavily reliant on a global network of distributors to reach end-users in hospitals, reference labs, and point-of-care settings.

Clinical chemistry and immunoturbidimetric reagent development for open-system automated and semi-automated photometric analyzers. Expertise in liquid-stable, ready-to-use assay formulations. Portfolio includes urinalysis via reflectance photometry with test strips.

DiaSys competes in a highly consolidated market dominated by multinational corporations like Roche, Abbott, Siemens Healthineers, and Danaher. Its competitive strategy is based on providing high-quality, cost-effective reagents for open analyzer systems, offering labs an alternative to proprietary reagents. It also competes with other specialty reagent manufacturers and regional players in specific geographies.